UBS Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-291,642
| Closed | -$24.8M | – | 9156 |
|
|
2020
Q3 | $24.8M | Buy |
291,642
+223,794
| +330% | +$11.3M | 0.01% | 1034 |
|
|
2020
Q2 | $2.4M | Buy |
67,848
+27,647
| +69% | +$808K | ﹤0.01% | 2701 |
|
|
2020
Q1 | $542K | Sell |
40,201
-132,778
| -77% | -$2.23M | ﹤0.01% | 3893 |
|
|
2019
Q4 | $3.66M | Sell |
172,979
-239,682
| -58% | -$4.23M | ﹤0.01% | 2907 |
|
|
2019
Q3 | $5.47M | Buy |
412,661
+231,639
| +128% | +$3.41M | ﹤0.01% | 2301 |
|
|
2019
Q2 | $2.51M | Buy |
181,022
+174,477
| +2,666% | +$2.63M | ﹤0.01% | 2943 |
|
|
2019
Q1 | $125K | Sell |
6,545
-105,608
| -94% | -$1.7M | ﹤0.01% | 4922 |
|
|
2018
Q4 | $1.6M | Buy |
112,153
+58,927
| +111% | +$1.17M | ﹤0.01% | 3258 |
|
|
2018
Q3 | $1.11M | Buy |
53,226
+43,775
| +463% | +$1.04M | ﹤0.01% | 3744 |
|
|
2018
Q2 | $224K | Sell |
9,451
-179,779
| -95% | -$3.61M | ﹤0.01% | 4860 |
|
|
2018
Q1 | $2.77M | Sell |
189,230
-170,740
| -47% | -$2.79M | ﹤0.01% | 2849 |
|
|
2017
Q4 | $5.82M | Buy |
359,970
+45,495
| +14% | +$537K | ﹤0.01% | 2204 |
|
|
2017
Q3 | $4.4M | Buy |
314,475
+244,311
| +348% | +$2.43M | ﹤0.01% | 2331 |
|
|
2017
Q2 | $620K | Buy |
70,164
+66,464
| +1,796% | +$467K | ﹤0.01% | 3970 |
|
|
2017
Q1 | $24K | Buy |
3,700
+1,000
| +37% | +$5.07K | ﹤0.01% | 6028 |
|
|
2016
Q4 | $10K | Hold |
2,700
| – | – | ﹤0.01% | 6942 |
|
|
2016
Q3 | $9K | Sell |
2,700
-21,292
| -89% | -$59.5K | ﹤0.01% | 6867 |
|
|
2016
Q2 | $56K | Buy |
23,992
+11,903
| +98% | +$39.8K | ﹤0.01% | 5442 |
|
|
2016
Q1 | $30K | Sell |
12,089
-9,574
| -44% | -$21.5K | ﹤0.01% | 5902 |
|
|
2015
Q4 | $66K | Buy |
21,663
+10,413
| +93% | +$29.1K | ﹤0.01% | 5578 |
|
|
2015
Q3 | $19K | Sell |
11,250
-10,640
| -49% | -$27.2K | ﹤0.01% | 6763 |
|
|
2015
Q2 | $89K | Hold |
21,890
| – | – | ﹤0.01% | 5497 |
|
|
2015
Q1 | $84K | Sell |
21,890
-7,190
| -25% | -$31.3K | ﹤0.01% | 5565 |
|
|
2014
Q4 | $140K | Buy |
+29,080
| New | +$115K | ﹤0.01% | 5356 |
|
UBS Group's IMMU Position: Q4 2020 in Review
UBS Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 291,642 shares — an estimated $24.8M sold.
UBS Group first reported a position in IMMU in Q4 2014 and held it in 24 quarters. The position peaked at $24.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- UBS Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- UBS Group sold 291,642 Immunomedics Inc shares in Q4 2020, an estimated $24.8M.
- UBS Group first reported a position in Immunomedics Inc in Q4 2014 and held it in 24 quarters.
- UBS Group's Immunomedics Inc position peaked at $24.8M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.